Catalyst Wire Dossier Catalyst Wire Dossier

Combination therapy: Salbutamol and Insulin Dextrose

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Combination therapy: Salbutamol and Insulin Dextrose, covering 2024-04-30 to 2024-04-30. Get the full timeline:

Most recent: Clinical Trial Update: Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia [Phase 4]

See pricing